Antiarrhythmic effects and mechanisms of sodium-glucose cotransporter 2 inhibitors: A mini review

被引：7
|
作者：
Wu, Jinchun [1 ]
Liu, Yanmin [1 ]
Wei, Xiaojuan [1 ]
Zhang, Xiaofei [1 ]
Ye, Yi [2 ]
Li, Wei [1 ]
Su, Xiaoling [1 ]
机构：
[1] Qinghai Prov Peoples Hosp, Dept Cardiol, Xining, Peoples R China
[2] Qinghai Univ, Grad Sch, Xining, Peoples R China
来源：
FRONTIERS IN CARDIOVASCULAR MEDICINE | 2022年 / 9卷
关键词：
Na+ homeostasis; Ca2+ homeostasis; Na+-H+ exchanger regulatory factor (NHERF)1; 2; Na+-Ca2+ exchanger (NCX); ventricular arrhythmia (VAs); atrial fibrillation; arrhythmia; sodium-glucose cotransporter 2 inhibitor; SUDDEN CARDIAC DEATH; SGLT2; INHIBITORS; HEART-FAILURE; VENTRICULAR-ARRHYTHMIAS; DIASTOLIC DYSFUNCTION; ATRIAL-FIBRILLATION; ARTERIAL STIFFNESS; NA+/H+ EXCHANGER; BLOOD-PRESSURE; EMPAGLIFLOZIN;
D O I：
10.3389/fcvm.2022.915455
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are a new type of oral hypoglycaemic agent with good cardiovascular protective effects. There are several lines of clinical evidence suggest that SGLT2i can significantly reduce the risks of heart failure, cardiovascular death, and delay the progression of chronic kidney disease. In addition, recent basic and clinical studies have also reported that SGLT2i also has good anti-arrhythmic effects. However, the exact mechanism is poorly understood. The aim of this review is to summarize recent clinical findings, studies of laboratory animals, and related study about this aspect of the antiarrhythmic effects of SGLT2i, to further explore its underlying mechanisms, safety, and prospects for clinical applications of it.
引用
收藏
页数：10
相关论文
共 50 条
  • [1] Sodium-Glucose Cotransporter 2 Inhibitors Mechanisms of Action: A Review
    Fonseca-Correa, Jorge I.
    Correa-Rotter, Ricardo
    FRONTIERS IN MEDICINE, 2021, 8
  • [2] Cardiovascular effects and mechanisms of sodium-glucose cotransporter-2 inhibitors
    Yang Fan
    Meng Ran
    Zhu Da-Long
    慢性疾病与转化医学（英文）, 2020, 06 (04) : 239 - 245
  • [3] CARDIOPROTECTIVE MECHANISMS OF SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITORS
    Mkrtumyan, Ashot M.
    Markova, Tatyana N.
    Mishchenko, Nadezhda K.
    DIABETES MELLITUS, 2021, 24 (03): : 291 - 299
  • [4] Lipid effects of sodium-glucose cotransporter 2 inhibitors
    Lazarte, Julieta
    Kanagalingam, Tharsan
    Hegele, Robert A.
    CURRENT OPINION IN LIPIDOLOGY, 2021, 32 (03) : 183 - 190
  • [5] Sodium-Glucose Cotransporter 2 Inhibitors with Renoprotective Effects
    Satirapoj, Bancha
    KIDNEY DISEASES, 2017, 3 (01) : 24 - 32
  • [6] Renoprotective effects of sodium-glucose cotransporter-2 inhibitors and underlying mechanisms
    Kashihara, Naoki
    Kidokoro, Kengo
    Kanda, Eiichiro
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2020, 29 (01): : 112 - 118
  • [7] Mechanisms of Sodium-glucose Cotransporter 2 Inhibitors in Heart Failure
    Wei, Jiangjun
    Du, Jianlin
    CARDIOVASCULAR INNOVATIONS AND APPLICATIONS, 2023, 8 (01)
  • [8] Sodium-Glucose Cotransporter 2 Inhibitors
    Erol, Cetin
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2024, 28 (05): : 216 - 216
  • [9] Mechanisms of Cardiorenal Effects of Sodium-Glucose Cotransporter 2 Inhibitors JACC State-of-the-Art Review
    Zelniker, Thomas A.
    Braunwald, Eugene
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (04) : 422 - 434
  • [10] A role for sodium-glucose cotransporter 2 inhibitors in the treatment of chronic kidney disease - A mini review
    Song, Jinfang
    Li, Xia
    Ni, Jiang
    KIDNEY & BLOOD PRESSURE RESEARCH, 2023, 48 (01): : 599 - 610
12345